Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Santa Barbara, California 93105


Purpose:

The Mil Familias Program is a 10-year initiative to reduce the burden of cardio-metabolic disease among Latino families in the Central Coast of California. The Mil Familias Program involves enrolling 1000 Latino families with at least one member in the family having type 2 diabetes, measuring the 5 determinants of human health: genetics, biology, behavior, psychology and environment, training Latino community health workers ("Especialistas") , creating a Living Information (bio)Bank and planning culturally-relevant interventions.


Study summary:

The Mil Familias Pilot Study aims to develop, operationalize and refine methods to both recruit and collect data from 100 adult participants pertaining to the 5 determinants of human health: genetics, biology, behavior, psychology and environment. Specially-trained Latino and bilingual community health workers known as "Especialistas" will be used to help gather data and to serve as the participants trustworthy health companion. Over 100 variables of information pertaining to the 5 determinants of human health (as listed above) will be gathered and stored to create a Living Information (bio)Bank particular to Latinos. The ultimate goal of this research is to provide the target population with effective, culturally-relevant interventions that are geared toward population specific needs.


Criteria:

Inclusion criteria: 1. Males or females ≥ 18 years of age at Visit 1 (screening and enrollment). 2. Self-reported Hispanic and/or Latino heritage. 3. Currently residing in Santa Barbara County, California. 4. Established diagnosis of Type 2 diabetes for at least one year prior to enrollment date. 5. Signed and dated written informed consent by the date of Visit 1. 6. Based on the research staff's judgment, subject must have a good understanding, ability, and willingness to adhere to the protocol, including performance of self-monitored data collection during the wearable device portion. Exclusion Criteria: 1. Diagnosed severe cardiovascular disease, within the 6 months prior to enrollment Visit 1, defined as: previous stroke; decompensated heart failure New York Heart Association class III or IV; myocardial infarction; unstable angina pectoris; or coronary arterial bypass graft or angioplasty. 2. Life expectancy < 2 years. 3. Any active clinically significant disease or disorder, which in the investigator's opinion could interfere with the participation of the trial. 4. Mental incapacity, psychiatric disorder, unwillingness or language barriers precluding comprehension of study activities and informed consent. 5. Participation in other trials involving medication or device within 1 month prior to Visit 1. 6. Known or suspected abuse of alcohol, narcotics, or illicit drugs.


NCT ID:

NCT03736486


Primary Contact:

Principal Investigator
David Kerr, M.D.
Sansum Diabetes Research Institute


Backup Contact:

N/A


Location Contact:

Santa Barbara, California 93105
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.